TardiMed Sciences LLC
10% Owner

TardiMed Sciences LLC insider trades: PaxMedica (PXMD) stock buys and sales

10% Owner, PaxMedica Last trade Aug 30, 2022 12 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2020
3
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where TardiMed Sciences LLC reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 30, 2022PXMD↑ Buy$499K
Sep 2, 2021TMBR↓ Sell$211K
Sep 1, 2021TMBR↓ Sell$368K
Aug 26, 2021TMBR↓ Sell$276K
Aug 20, 2021TMBR↓ Sell$168K
Jun 15, 2021TMBR↓ Sell$221K
Jun 10, 2021TMBR↓ Sell$750K
Jun 2, 2021TMBR↓ Sell$84K
Sep 16, 2020TMBR↓ Sell$194K
Sep 11, 2020TMBR↓ Sell$42K
Feb 10, 2020BPMX↓ Sell$550

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About TardiMed Sciences LLC's insider trades

TardiMed Sciences LLC is a 10% owner of PaxMedica (PXMD). Since Feb 10, 2020, it has reported 1 open-market purchase worth $499K and 10 sales worth $2.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PXMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.